Literature DB >> 26597493

Genetic heterogeneity in 26 infants with a hypomyelinating leukodystrophy.

Natsuko Arai-Ichinoi1, Mitsugu Uematsu2, Ryo Sato1, Tasuku Suzuki1, Hiroki Kudo1, Atsuo Kikuchi1, Naomi Hino-Fukuyo1, Mitsuyo Matsumoto3,4, Kazuhiko Igarashi3, Kazuhiro Haginoya5, Shigeo Kure1.   

Abstract

T2 hyperintensity of brain white matter lesions detected by magnetic resonance imaging (MRI) are characteristic of a heterogeneous group of diseases. Persistent T2 high intensity in combination with T1 iso- or high intensity of white matter in infants indicates a lack of normal myelination, that is, hypomyelination. However, the precise diagnosis of hypomyelinating leukodystrophy based solely on MRI findings can be difficult, especially in the early stage of the disease. We studied 26 patients who were diagnosed with hypomyelinating leukodystrophy according to MRI findings and clinical features to uncover their genetic etiology through chromosomal analyses, targeted gene analyses, and an array comparative genomic hybridization (aCGH) assay. Then, for the 17 patients with unexplained hypomyelination by traditional analyses, whole-exome sequencing (WES) was performed. The presumptive diagnoses were confirmed in 58 % of the enrolled patients (15/26) and involved 9 different genetic backgrounds. The most frequent backgrounds were 18q deletion syndrome and Pelizaeus-Merzbacher disease, with an incidence of 12 % (3/26) for both. The diagnostic rate of chromosomal analyses, targeted gene analyses, and aCGH was 31 % (8/26), and one patient was clinically diagnosed with Cockayne syndrome. Using WES, the following causative genes of hypomyelination were identified in six individuals (35 %, 6/17): TUBB4A, POLR3B, KCNT1, and MCOLN1, and some of those genes were pathogenic for not only hypomyelination but also dysmyelination or delayed myelination. Our findings suggested heterogeneous genetic backgrounds in patients with persistent white matter lesions. These data also indicate that WES may be a rapid and useful tool for identifying the underlying genetic causes of undiagnosed leukodystrophies.

Entities:  

Mesh:

Year:  2015        PMID: 26597493     DOI: 10.1007/s00439-015-1617-7

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  37 in total

1.  White matter changes associated with deletions of the long arm of chromosome 18 (18q- syndrome): a dysmyelinating disorder?

Authors:  L A Loevner; R M Shapiro; R I Grossman; J Overhauser; J Kamholz
Journal:  AJNR Am J Neuroradiol       Date:  1996 Nov-Dec       Impact factor: 3.825

Review 2.  Concepts of myelin and myelination in neuroradiology.

Authors:  A J Barkovich
Journal:  AJNR Am J Neuroradiol       Date:  2000 Jun-Jul       Impact factor: 3.825

3.  Magnetic resonance imaging pattern recognition in hypomyelinating disorders.

Authors:  Marjan E Steenweg; Adeline Vanderver; Susan Blaser; Alberto Bizzi; Tom J de Koning; Grazia M S Mancini; Wessel N van Wieringen; Frederik Barkhof; Nicole I Wolf; Marjo S van der Knaap
Journal:  Brain       Date:  2010-10       Impact factor: 13.501

Review 4.  A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.

Authors:  Sumit Parikh; Geneviève Bernard; Marc C Patterson; Ryan J Taft; Adeline Vanderver; Richard J Leventer; Marjo S van der Knaap; Johan van Hove; Amy Pizzino; Nathan H McNeill; Guy Helman; Cas Simons; Johanna L Schmidt; William B Rizzo
Journal:  Mol Genet Metab       Date:  2014-12-29       Impact factor: 4.797

5.  Invited article: an MRI-based approach to the diagnosis of white matter disorders.

Authors:  Raphael Schiffmann; Marjo S van der Knaap
Journal:  Neurology       Date:  2009-02-24       Impact factor: 9.910

6.  A de novo mutation in the β-tubulin gene TUBB4A results in the leukoencephalopathy hypomyelination with atrophy of the basal ganglia and cerebellum.

Authors:  Cas Simons; Nicole I Wolf; Nathan McNeil; Ljubica Caldovic; Joseph M Devaney; Asako Takanohashi; Joanna Crawford; Kelin Ru; Sean M Grimmond; David Miller; Davide Tonduti; Johanna L Schmidt; Robert S Chudnow; Rudy van Coster; Lieven Lagae; Jill Kisler; Jürgen Sperner; Marjo S van der Knaap; Raphael Schiffmann; Ryan J Taft; Adeline Vanderver
Journal:  Am J Hum Genet       Date:  2013-04-11       Impact factor: 11.025

Review 7.  Exome sequence read depth methods for identifying copy number changes.

Authors:  Latha Kadalayil; Sajjad Rafiq; Matthew J J Rose-Zerilli; Reuben J Pengelly; Helen Parker; David Oscier; Jonathan C Strefford; William J Tapper; Jane Gibson; Sarah Ennis; Andrew Collins
Journal:  Brief Bioinform       Date:  2014-08-28       Impact factor: 11.622

8.  The neurogenetics of mucolipidosis type IV.

Authors:  G Altarescu; M Sun; D F Moore; J A Smith; E A Wiggs; B I Solomon; N J Patronas; K P Frei; S Gupta; C R Kaneski; O W Quarrell; S A Slaugenhaupt; E Goldin; R Schiffmann
Journal:  Neurology       Date:  2002-08-13       Impact factor: 9.910

9.  Epidemiological, clinical, and genetic landscapes of hypomyelinating leukodystrophies.

Authors:  Yurika Numata; Leo Gotoh; Akiko Iwaki; Kenji Kurosawa; Jun-Ichi Takanashi; Kimiko Deguchi; Toshiyuki Yamamoto; Hitoshi Osaka; Ken Inoue
Journal:  J Neurol       Date:  2014-02-16       Impact factor: 4.849

Review 10.  Hypomyelinating leukodystrophies: translational research progress and prospects.

Authors:  Petra J W Pouwels; Adeline Vanderver; Genevieve Bernard; Nicole I Wolf; Steffi F Dreha-Kulczewksi; Sean C L Deoni; Enrico Bertini; Alfried Kohlschütter; William Richardson; Charles Ffrench-Constant; Wolfgang Köhler; David Rowitch; A James Barkovich
Journal:  Ann Neurol       Date:  2014-06-24       Impact factor: 10.422

View more
  12 in total

1.  Phactr1 regulates Slack (KCNT1) channels via protein phosphatase 1 (PP1).

Authors:  Syed Rydwan Ali; Taylor Joseph Malone; Yalan Zhang; Magdalena Prechova; Leonard Konrad Kaczmarek
Journal:  FASEB J       Date:  2019-12-02       Impact factor: 5.191

2.  Understanding molecular mechanisms and predicting phenotypic effects of pathogenic tubulin mutations.

Authors:  Thomas J Attard; Julie P I Welburn; Joseph A Marsh
Journal:  PLoS Comput Biol       Date:  2022-10-07       Impact factor: 4.779

Review 3.  Hypomyelinating leukodystrophies - unravelling myelin biology.

Authors:  Nicole I Wolf; Charles Ffrench-Constant; Marjo S van der Knaap
Journal:  Nat Rev Neurol       Date:  2020-12-15       Impact factor: 42.937

4.  A novel TUBB4A mutation G96R identified in a patient with hypomyelinating leukodystrophy onset beyond adolescence.

Authors:  Yongping Lu; Yumiko Ondo; Keiko Shimojima; Hitoshi Osaka; Toshiyuki Yamamoto
Journal:  Hum Genome Var       Date:  2017-08-03

5.  Functional consequences of a KCNT1 variant associated with status dystonicus and early-onset infantile encephalopathy.

Authors:  Tracy S Gertler; Christopher H Thompson; Carlos G Vanoye; John J Millichap; Alfred L George
Journal:  Ann Clin Transl Neurol       Date:  2019-07-15       Impact factor: 4.511

Review 6.  Altered Expression of Ion Channels in White Matter Lesions of Progressive Multiple Sclerosis: What Do We Know About Their Function?

Authors:  Francesca Boscia; Maria Louise Elkjaer; Zsolt Illes; Maria Kukley
Journal:  Front Cell Neurosci       Date:  2021-06-25       Impact factor: 5.505

7.  Clinical and molecular characterization of KCNT1-related severe early-onset epilepsy.

Authors:  Amy McTague; Umesh Nair; Sony Malhotra; Esther Meyer; Natalie Trump; Elena V Gazina; Apostolos Papandreou; Adeline Ngoh; Sally Ackermann; Gautam Ambegaonkar; Richard Appleton; Archana Desurkar; Christin Eltze; Rachel Kneen; Ajith V Kumar; Karine Lascelles; Tara Montgomery; Venkateswaran Ramesh; Rajib Samanta; Richard H Scott; Jeen Tan; William Whitehouse; Annapurna Poduri; Ingrid E Scheffer; W K Kling Chong; J Helen Cross; Maya Topf; Steven Petrou; Manju A Kurian
Journal:  Neurology       Date:  2017-12-01       Impact factor: 9.910

8.  Canine NAPEPLD-associated models of human myelin disorders.

Authors:  K M Minor; A Letko; D Becker; M Drögemüller; P J J Mandigers; S R Bellekom; P A J Leegwater; Q E M Stassen; K Putschbach; A Fischer; T Flegel; K Matiasek; K J Ekenstedt; E Furrow; E E Patterson; S R Platt; P A Kelly; J P Cassidy; G D Shelton; K Lucot; D L Bannasch; H Martineau; C F Muir; S L Priestnall; D Henke; A Oevermann; V Jagannathan; J R Mickelson; C Drögemüller
Journal:  Sci Rep       Date:  2018-04-11       Impact factor: 4.379

9.  Hypomyelinating disorders in China: The clinical and genetic heterogeneity in 119 patients.

Authors:  Haoran Ji; Dongxiao Li; Ye Wu; Quanli Zhang; Qiang Gu; Han Xie; Taoyun Ji; Huifang Wang; Lu Zhao; Haijuan Zhao; Yanling Yang; Hongchun Feng; Hui Xiong; Jinhua Ji; Zhixian Yang; Liping Kou; Ming Li; Xinhua Bao; Xingzhi Chang; Yuehua Zhang; Li Li; Huijuan Li; Zhengping Niu; Xiru Wu; Jiangxi Xiao; Yuwu Jiang; Jingmin Wang
Journal:  PLoS One       Date:  2018-02-16       Impact factor: 3.240

Review 10.  Microtubule Dysfunction: A Common Feature of Neurodegenerative Diseases.

Authors:  Antonella Sferra; Francesco Nicita; Enrico Bertini
Journal:  Int J Mol Sci       Date:  2020-10-05       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.